Phase 3 Dose Selection for Selinexor in Tp53Wt Endometrial Cancer Based on Exposure-Response Analysis.
AuthID
P-017-VJW
P-017-VJW
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service